Cargando…
Emicizumab-induced photosensitivity
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communic...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303071/ https://www.ncbi.nlm.nih.gov/pubmed/36046207 http://dx.doi.org/10.1055/s-0042-1749092 |
| _version_ | 1784751771758886912 |
|---|---|
| author | Asensi Cantó, Pedro Rodríguez Serna, Mercedes Lloret Madrid, Pilar Solís Ruiz, Jürgen Cid Haro, Ana Rosa Bonanad Boix, Santiago Haya Guaita, Saturnino |
| author_facet | Asensi Cantó, Pedro Rodríguez Serna, Mercedes Lloret Madrid, Pilar Solís Ruiz, Jürgen Cid Haro, Ana Rosa Bonanad Boix, Santiago Haya Guaita, Saturnino |
| author_sort | Asensi Cantó, Pedro |
| collection | PubMed |
| description | Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present. |
| format | Online Article Text |
| id | pubmed-9303071 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93030712022-08-30 Emicizumab-induced photosensitivity Asensi Cantó, Pedro Rodríguez Serna, Mercedes Lloret Madrid, Pilar Solís Ruiz, Jürgen Cid Haro, Ana Rosa Bonanad Boix, Santiago Haya Guaita, Saturnino TH Open Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present. Georg Thieme Verlag KG 2022-07-21 /pmc/articles/PMC9303071/ /pubmed/36046207 http://dx.doi.org/10.1055/s-0042-1749092 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Asensi Cantó, Pedro Rodríguez Serna, Mercedes Lloret Madrid, Pilar Solís Ruiz, Jürgen Cid Haro, Ana Rosa Bonanad Boix, Santiago Haya Guaita, Saturnino Emicizumab-induced photosensitivity |
| title | Emicizumab-induced photosensitivity |
| title_full | Emicizumab-induced photosensitivity |
| title_fullStr | Emicizumab-induced photosensitivity |
| title_full_unstemmed | Emicizumab-induced photosensitivity |
| title_short | Emicizumab-induced photosensitivity |
| title_sort | emicizumab-induced photosensitivity |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303071/ https://www.ncbi.nlm.nih.gov/pubmed/36046207 http://dx.doi.org/10.1055/s-0042-1749092 |
| work_keys_str_mv | AT asensicantopedro emicizumabinducedphotosensitivity AT rodriguezsernamercedes emicizumabinducedphotosensitivity AT lloretmadridpilar emicizumabinducedphotosensitivity AT solisruizjurgen emicizumabinducedphotosensitivity AT cidharoanarosa emicizumabinducedphotosensitivity AT bonanadboixsantiago emicizumabinducedphotosensitivity AT hayaguaitasaturnino emicizumabinducedphotosensitivity |